Department of Medicine, University of Washington, 1959 Northeast Pacific Street, Box #356421, Seattle, WA 98195, USA.
Med Clin North Am. 2013 Jul;97(4):737-57, xii. doi: 10.1016/j.mcna.2013.03.006. Epub 2013 Apr 29.
Antimicrobial resistance of urinary pathogens is increasing. Most urinary tract infections (UTIs) should still be treated empirically. However, patients with recurrence or other risk factors for resistance may benefit from urine culture. Patients with recurrent UTI often resort to antibiotic prevention, a risky proposition in terms of resistance. Non-antimicrobial preventative methods should be considered first. If preventative antibiotics must be used, postcoital patient-initiated protocols are effective and reduce overall antibiotic exposure compared with continuous prophylaxis. Consider referring patients for urologic evaluation when at risk for complicated UTIs or when recurrence continues despite conservative interventions.
尿路上皮病原体的耐药性在不断增加。大多数下尿路感染(UTI)仍应经验性治疗。然而,对于复发或存在其他耐药危险因素的患者,尿培养可能会带来获益。反复发生 UTI 的患者通常会采用抗生素预防,而这会增加耐药的风险。首先应考虑非抗菌预防性方法。如果必须使用预防性抗生素,那么与连续预防相比,性交后患者启动的方案更有效,且减少了整体抗生素暴露。当存在复杂性 UTI 风险或保守干预后仍持续复发时,考虑将患者转至泌尿科进行评估。